Director/PDMR Shareholding

RNS Number : 8508R
MyCelx Technologies Corporation
09 November 2021
 

9 November 2021

 

Mycelx Technologies Corporation

("Mycelx" or the "Company" (AIM: MYX)

 

 

Dealing by Director

 

The Company announces that it was notified on 9 November 2021 by Connie Mixon, Chief Executive Officer and a Director of the Company, that on 9 November 2021 she purchased 24,000 Common Shares at a price of £0.60 per Common Share. Following this transaction, she continues to be interested in 2,514,469 Common Shares representing 12.93 per cent of the present issued capital of the Company and in 413,017 options over the Company's Common Shares.

 

The aggregate number of Common Shares held by Ms. Mixon also includes (a) 150,000 shares held by limited liability companies controlled by Ms. Mixon; (b) 202,646 shares held by or on behalf of Ms. Mixon's children; and (c) 10,000 shares which are held by the estate of her late husband Mark Mixon as a custodian.

 

 

For further information please contact:

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

 

Tel: +1 888 306 6843

Canaccord Genuity, Nominated Adviser

Henry Fitzgerald-O'Connor

Georgina McCooke

 

 

Tel: + 44 20 7523 8000

Celicourt

Mark Antelme

Jimmy Lea

 

Tel: +44 20 8434 2754

 

Notification of transactions of persons discharging managerial responsibility or connected persons

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Connie Mixon

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Mycelx Technologies Corporation

b)

 

LEI

 

 

213800UJZINIK2VD1G48

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Common shares of US$0.025

 

 

USU624551078

 

 

b)

 

Nature of the transaction

 

 

Purchase of Common Shares

 

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

£0.60

 

24,000

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

n/a

 

 

n/a

 

 

e)

 

Date of the transaction

 

 

9/11/2021

f)

 

Place of the transaction

 

 

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFVRLALAIIL
UK 100

Latest directors dealings